Abstract:At the time of the first Transgenic Animal Research Conference, the lack of knowledge about promoter, enhancer and coding regions of genes of interest greatly hampered our efforts to create transgenes that would express appropriately in livestock. Additionally, we were limited to gene insertion by pronuclear microinjection. As predicted then, widespread genome sequencing efforts and technological advancements have profoundly altered what we can do. There have been many developments in technology to create transgenic animals since we first met at Granlibakken in 1997, including the advent of somatic cell nuclear transfer-based cloning and gene editing. We can now create new transgenes that will express when and where we want and can target precisely in the genome where we want to make a change or insert a transgene. With the large number of sequenced genomes, we have unprecedented access to sequence information including, control regions, coding regions, and known allelic variants. These technological developments have ushered in new and renewed enthusiasm for the production of transgenic animals among scientists and animal agriculturalists around the world, both for the production of more relevant biomedical research models as well as for agricultural applications. However, even though great advancements have been made in our ability to control gene expression and target genetic changes in our animals, there still are no genetically engineered animal products on the market for food. World-wide there has been a failure of the regulatory processes to effectively move forward. Estimates suggest the world will need to increase our current food production 70 % by 2050; that is we will have to produce the total amount of food each year that has been consumed by mankind over the past 500 years. The combination of transgenic animal technology and gene editing will become increasingly more important tools to help feed the world. However, to date the practical benefits of these technologies have not yet reached consumers in any country and in the absence of predictable, science-based regulatory programs it is unlikely that the benefits will be realized in the short to medium term.

Effective forgery detection using DCT+SVD-based watermarking for region of interest in key frames of vision-based surveillance

Advances in Genetic Engineering of Domestic Animals

Recent advances in the development of new transgenic animal technology

Genetically engineered livestock for agriculture: a generation after the first transgenic animal research conference

Traumatic thrombosis of the middle cerebral artery.

Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination

How genome editing changed the world of large animal research

The transgenic animal platform for biopharmaceutical production

Perspectives in Genome-Editing Techniques for Livestock

Advances in genetic engineering of the avian genome: “Realising the promise”

Limitations of Stroke Volume Estimation by Non-Invasive Blood Pressure Monitoring in Hypergravity

Measurement by Epigastric Impedance of Gastric Emptying in Diabetic Autonomic Neuropathy

[The Improvement and Application of Piggybac Transposon System in Mammals].

A Review of the Use of Genetic Engineering Practices and the Impact of Gene Editing in Healthcare and Biotechnology

Revolutionizing animal husbandry: Breakthroughs in gene editing delivery systems

Improvements in Gene Editing Technology Boost Its Applications in Livestock

Comparison of two methods of sperm‐ and testis‐mediated gene transfer in production of transgenic animals: A systematic review

New routes for transgenesis of the mouse

Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species

The Application Prospect of Induced Pluripotent Stem Cells in Pig Transgenic Research

Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals